l-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine has been researched along with 3-methoxytyrosine in 1 studies
| Studies (l-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine) | Trials (l-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine) | Recent Studies (post-2010) (l-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine) | Studies (3-methoxytyrosine) | Trials (3-methoxytyrosine) | Recent Studies (post-2010) (3-methoxytyrosine) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 186 | 34 | 27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hisaka, A; Ihara, M; Sawasaki, Y; Takehana, H; Tomimoto, K; Tsuchiya, Y; Yano, M | 1 |
1 other study(ies) available for l-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine and 3-methoxytyrosine
| Article | Year |
|---|---|
A new potential prodrug to improve the duration of L-dopa: L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine.
Topics: Animals; Biological Availability; Carbidopa; Chromatography, High Pressure Liquid; Dogs; Levodopa; Male; Prodrugs; Rats; Rats, Inbred Strains; Tyrosine | 1989 |